BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19417176)

  • 1. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons.
    Braga MF; Aroniadou-Anderjaska V; Li H; Rogawski MA
    J Pharmacol Exp Ther; 2009 Aug; 330(2):558-66. PubMed ID: 19417176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors.
    Aroniadou-Anderjaska V; Pidoplichko VI; Figueiredo TH; Almeida-Suhett CP; Prager EM; Braga MF
    Neuroscience; 2012 Sep; 221():157-69. PubMed ID: 22796081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala.
    Braga MF; Aroniadou-Anderjaska V; Xie J; Li H
    J Neurosci; 2003 Jan; 23(2):442-52. PubMed ID: 12533604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol antagonizes kainate receptor-mediated inhibition of evoked GABA(A) inhibitory postsynaptic currents in the rat hippocampal CA1 region.
    Crowder TL; Ariwodola OJ; Weiner JL
    J Pharmacol Exp Ther; 2002 Dec; 303(3):937-44. PubMed ID: 12438512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders.
    Aroniadou-Anderjaska V; Qashu F; Braga MF
    Amino Acids; 2007; 32(3):305-15. PubMed ID: 17048126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.
    Gryder DS; Rogawski MA
    J Neurosci; 2003 Aug; 23(18):7069-74. PubMed ID: 12904467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist.
    Kaminski RM; Banerjee M; Rogawski MA
    Neuropharmacology; 2004 Jun; 46(8):1097-104. PubMed ID: 15111016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor-JNK3 pathway via GABA(A) receptors.
    Lv Q; Liu Y; Han D; Xu J; Zong YY; Wang Y; Zhang GY
    Brain Res; 2012 May; 1456():1-13. PubMed ID: 22516108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala.
    Läck AK; Ariwodola OJ; Chappell AM; Weiner JL; McCool BA
    Neuropharmacology; 2008 Oct; 55(5):661-8. PubMed ID: 18617194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic modulation of neurotransmission in the rat basolateral amygdala.
    Rainnie DG
    J Neurophysiol; 1999 Jul; 82(1):69-85. PubMed ID: 10400936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte-mediated activation of neuronal kainate receptors.
    Liu QS; Xu Q; Arcuino G; Kang J; Nedergaard M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3172-7. PubMed ID: 14766987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons.
    Yu B; Shinnick-Gallagher P
    J Pharmacol Exp Ther; 1994 Nov; 271(2):590-600. PubMed ID: 7525939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic inactivation of action potentials and postsynaptic inhibition of GABAA currents contribute to KA-induced disinhibition in CA1 pyramidal neurons.
    Kang N; Jiang L; He W; Xu J; Nedergaard M; Kang J
    J Neurophysiol; 2004 Aug; 92(2):873-82. PubMed ID: 14999044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells.
    Cossart R; Esclapez M; Hirsch JC; Bernard C; Ben-Ari Y
    Nat Neurosci; 1998 Oct; 1(6):470-8. PubMed ID: 10196544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis.
    Fritsch B; Qashu F; Figueiredo TH; Aroniadou-Anderjaska V; Rogawski MA; Braga MF
    Neuroscience; 2009 Sep; 163(1):415-29. PubMed ID: 19540312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainate receptors and signal integration by NG2 glial cells.
    Kukley M; Dietrich D
    Neuron Glia Biol; 2009 May; 5(1-2):13-20. PubMed ID: 20025816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine modulates excitability of basolateral amygdala neurons in vitro.
    Kröner S; Rosenkranz JA; Grace AA; Barrionuevo G
    J Neurophysiol; 2005 Mar; 93(3):1598-610. PubMed ID: 15537813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mechanisms of ethanol potentiation of local and paracapsular GABAergic synapses in the rat basolateral amygdala.
    Silberman Y; Shi L; Brunso-Bechtold JK; Weiner JL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):251-60. PubMed ID: 17921186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis.
    Fritsch B; Reis J; Gasior M; Kaminski RM; Rogawski MA
    J Neurosci; 2014 Apr; 34(17):5765-75. PubMed ID: 24760837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GluR5 kainate receptors, seizures, and the amygdala.
    Rogawski MA; Gryder D; Castaneda D; Yonekawa W; Banks MK; Lia H
    Ann N Y Acad Sci; 2003 Apr; 985():150-62. PubMed ID: 12724156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.